INC Research announced a strategic collaboration with DrugDev to complete integration with and implementation of DrugDev’s SiteCloud platform.
INC Research announced a strategic collaboration with DrugDev to complete integration with and implementation of DrugDev’s SiteCloud platform. The SiteCloud platform is the same technology used by TransCelerate’s Investigator Registry and the Investigator Databank. Using a universal identifier within the platform allows INC to match data from numerous disparate sources--such as its internal experience, the DrugDev Network of 80,000 opted-in global investigators across 115 countries and trusted third-party resources--to create a virtual private database for INC with site and investigator profiles that will be used to make evidence-based decisions.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.